Skip to main content

D. E. Shaw & Co., Inc.

Position in REPL — Replimune Group, Inc.

CIK 1009207 New York, NY

Position in REPL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$19,814,901
+$1,940,463 QoQ
Shares Held
1,789,964
-23.4% QoQ
Ownership
1.90%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#16
of 199 holders
Holding Since
Sep 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REPL Over Time

Shares Held

Position Value (USD)

Derivatives in REPL

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$2,214,000
PutShares
200,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $5,139,216,221 across 217 Biotechnology names. REPL ranks #51 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in REPL

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $19,814,901 1,789,964
2026-06-30 $2,214,000 200,000
2026-03-31 $17,874,438 2,336,528
2025-12-31 $25,029,408 2,575,042
2025-09-30 $1,690,643 403,495
2025-06-30 $4,706,276 506,596
2025-03-31 $7,766,654 796,580
2024-12-31 $11,777,882 972,575
2024-09-30 $9,509,805 867,683
2024-06-30 $8,386,020 931,780
2024-03-31 $8,151,910 997,786
2023-12-31 $2,048,539 243,006
2023-09-30 $1,380,828 80,703
2023-06-30 $2,033,654 87,582
2023-03-31 $2,404,214 136,139
2022-12-31 $3,507,956 128,969
2022-03-31 $321,295 18,922
2021-03-31 $3,699,551 121,257
2020-12-31 $4,088,115 107,159
2020-09-30 $644,467 27,996